Maria Stangou Selected Research

Maria Stangou Research Topics

Disease

11	IGA Glomerulonephritis (IGA Nephropathy) 05/2021 - 07/2004
7	Proteinuria 01/2022 - 01/2005
5	Glomerulonephritis 01/2021 - 02/2010
4	Fibrosis (Cirrhosis) 01/2020 - 01/2005
3	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2022 - 07/2017
3	Atrophy 01/2020 - 01/2008
3	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 07/2017 - 01/2008
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 02/2021
2	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2022 - 07/2017
2	Segmental glomerulosclerosis 01/2020 - 01/2019
2	Membranous Glomerulonephritis (Membranous Nephropathy) 06/2019 - 01/2019
1	Relapsing-Remitting Multiple Sclerosis 01/2022
1	Chronic Progressive Multiple Sclerosis 01/2022
1	Arteriovenous Fistula 10/2021
1	Vascular Calcification 10/2021
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2021
1	Anemia 01/2020
1	Renal Insufficiency (Renal Failure) 01/2020
1	Sclerosis 07/2017
1	Hypertension (High Blood Pressure) 11/2011
1	Disease Progression 11/2011
1	Nephritis 01/2011
1	Hypovolemia 01/2011
1	Body Weight (Weight, Body) 01/2011
1	Anuria 01/2008
1	Inflammation (Inflammations) 01/2008
1	Barakat syndrome 04/2005
1	Hypoparathyroidism 04/2005
1	Deafness (Deaf Mutism) 04/2005
1	Sepsis (Septicemia) 01/2005
1	Rapidly progressive glomerulonephritis with pulmonary hemorrhage 01/2005
1	Vasculitis (Vasculitides) 01/2005
1	Calcinosis 10/2002
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 06/2002

Drug/Important Bio-Agent (IBA)

4	CreatinineIBA 01/2022 - 01/2005
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2016
3	SteroidsIBA 01/2022 - 06/2011
3	Immunoglobulin A (IgA)IBA 05/2021 - 02/2010
3	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021 - 01/2005
3	Azathioprine (Imuran)FDA LinkGeneric 02/2018 - 06/2011
3	CytokinesIBA 07/2017 - 09/2009
2	galactosyl-deficient IgA1IBA 05/2021 - 03/2016
2	Complement System Proteins (Complement)IBA 01/2021 - 01/2019
2	AutoantibodiesIBA 06/2019 - 02/2010
2	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2018 - 01/2005
2	Interleukin-2 (IL2)IBA 07/2017 - 09/2013
1	Serum AlbuminIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	Immunoglobulin D (IgD)IBA 01/2022
1	ocrelizumabIBA 01/2022
1	myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA 10/2021
1	MicroRNAs (MicroRNA)IBA 05/2021
1	Complement Factor B (Factor B)IBA 01/2021
1	3- ((5- (6- methylpyridin- 2- yl)- 4- (quinoxalin- 6- yl)- 1H- imidazol- 2- yl)methyl)benzamideIBA 01/2020
1	ParaffinIBA 01/2020
1	IronIBA 01/2020
1	sucroferric oxyhydroxideIBA 01/2020
1	Formaldehyde (Formol)FDA Link 01/2020
1	AntibodiesIBA 06/2019
1	Phospholipase A2 ReceptorsIBA 06/2019
1	Complement Inactivating AgentsIBA 01/2019
1	Calcineurin InhibitorsIBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Methylprednisolone FDA LinkGeneric 02/2018
1	Prednisolone (Predate)FDA LinkGeneric 02/2018
1	Interleukin-12 (IL 12)IBA 07/2017
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 07/2017
1	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 11/2011
1	AldosteroneIBA 11/2011
1	Proteins (Proteins, Gene)FDA Link 06/2011
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 06/2011
1	oprelvekin (Neumega)FDA Link 01/2011
1	Vasopressins (Vasopressin)IBA 01/2011
1	Fibronectins (Fibronectin)IBA 01/2011
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2011
1	Interleukin-11 (Interleukin 11)IBA 01/2011
1	Myeloblastin (Proteinase 3)IBA 02/2010
1	Peroxidase (Myeloperoxidase)IBA 02/2010
1	Epidermal Growth Factor (EGF)IBA 09/2009
1	Interleukin-6 (Interleukin 6)IBA 09/2009
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 09/2009
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2008
1	Transcription Factors (Transcription Factor)IBA 04/2005
1	DNA (Deoxyribonucleic Acid)IBA 04/2005
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2005
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 07/2004
1	Pharmaceutical PreparationsIBA 06/2002

Therapy/Procedure

4	Renal Dialysis (Hemodialysis) 01/2022 - 10/2002
2	Therapeutics 01/2020 - 06/2002
1	Hemodiafiltration 01/2022
1	Continuous Ambulatory Peritoneal Dialysis (CAPD) 02/2021
1	Aftercare (After-Treatment) 01/2005
1	Plasma Exchange 06/2002